WO2024028846 - COMBINATION THERAPY FOR TREATING CANCERS

National phase entry:
Publication Number WO/2024/028846
Publication Date 08.02.2024
International Application No. PCT/IB2023/057934
International Filing Date 05.08.2023
Title **
[English] COMBINATION THERAPY FOR TREATING CANCERS
[French] POLYTHÉRAPIE POUR TRAITEMENT DES CANCERS
Applicants **
GEISTLICH PHARMA AG
Inventors
COSTIN, James C.
MOEHLER, Hanns
Priority Data
63/370,570   05.08.2022   US
63/504,377   25.05.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2785
EPO Filing, Examination, Granting17231
Japan Filing, Examination, Granting2649
South Korea Filing, Examination, Granting3110
USA Filing, Examination, Granting6940
MasterCard Visa
Total: 32,715

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] are independently, H, alkyl, an aryl, a substituted alkyl, a substituted phenyl, a substituted aryl, or a combination thereof.[French] sont indépendamment H, alkyle, un aryle, un alkyle substitué, un phényle substitué, un aryle substitué ou une association de ceux-ci.